The DOI matches its Crossref record; 122 of the 122 references it cites were found in a registry or an index.
The Polyethyleneglycol Dilemma: Advantage and Disadvantage of PEGylation of Liposomes for Systemic Genes and Nucleic Acids Delivery to Tumors
Open accessAbstract
Gene and nucleic acid therapy is expected to play a major role in the next generation of agents for cancer treatment. We have recently developed a multifunctional envelope-type nano device (MEND) for use as a novel nonviral gene delivery system. The modification of polyethyleneglycol (PEG), i.e., PEGylation, is a useful method for achieving a longer circulation time for the delivery of MEND to a tumor via the enhanced permeability and retention (EPR) effect. However, PEGylation strongly inhibits cellular uptake and endosomal escape, which results in significant loss of activity of the delivery system. For successful nucleic acid delivery for cancer treatment, the crucial problem associated with the use of PEG, i.e., the "PEG dilemma" must be resolved. In this review, we describe the development and applications of MEND and discuss various strategies for overcoming the PEG dilemma based on the manipulation of both pharmacokinetics and intracellular trafficking of cellular uptake and endosomal release. To increase cellular uptake, target ligands including proteins, peptides, antibodies and aptamers that recognize molecules specifically expressed on tumors are first introduced. Second, cleavable PEG systems are described. The cleavage of PEG from carriers was achieved in response to the intracellular environment as well as the tumor microenvironment, which improvs cellular uptake and endosomal escape. Then, endosomal fusogenic peptides are discussed. Finally, pH-sensitive liposomes using pH-sensitive lipids are described.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors
Kawai, T., & Akira, S. (2010) · Nature Immunology · doi:10.1038/ni.1863 · Cited by 9,304
Matsumura, Y., & Maeda, H. (1986) · PubMed · Cited by 6,781
Recent advances with liposomes as pharmaceutical carriers
Torchilin, V. P. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1632 · Cited by 5,282
Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure.
Felgner, P. L., Gadek, T. R., Holm, M., Roman, R., Chan, H. W., Wenz, M., Northrop, J. P., Ringold, G. M., & Danielsen, M. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.21.7413 · Cited by 4,978
Liposomal drug delivery systems: From concept to clinical applications
Allen, T. M., & Cullis, P. R. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.037 · Cited by 4,839
Nanoparticle therapeutics: an emerging treatment modality for cancer
Davis, M. E., Chen, Z., & Shin, D. M. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2614 · Cited by 4,233
Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles
Davis, M. E., Zuckerman, J. E., Choi, C. H. J., Seligson, D., Tolcher, A., Alabi, C. A., Yen, Y., Heidel, J. D., & Ribas, A. (2010) · Nature · doi:10.1038/nature08956 · Cited by 2,505
Cancer Treatment by Targeted Drug Delivery to Tumor Vasculature in a Mouse Model
Arap, W., Pasqualini, R., & Ruoslahti, E. (1998) · Science · doi:10.1126/science.279.5349.377 · Cited by 2,054
Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes
Klibanov, A. L., Maruyama, K., Torchilin, V. P., & Huang, L. (1990) · FEBS Letters · doi:10.1016/0014-5793(90)81016-h · Cited by 2,027
New-Concept Chemotherapy by Nanoparticles of Biodegradable Polymers: Where Are We Now?
Feng, S.-S. (2006) · Nanomedicine · doi:10.2217/17435889.1.3.297 · Cited by 1,951
Ligand-targeted therapeutics in anticancer therapy
Allen, T. M. (2002) · Nature Reviews Cancer · doi:10.1038/nrc903 · Cited by 1,647
Papahadjopoulos, D., Allen, T. M., Gabizon, A., Mayhew, E., Matthay, K., Huang, S. K., Lee, K. D., Woodle, M. C., Lasic, D. D., & Redemann, C. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.24.11460 · Cited by 1,620
Allen, T. M., Hansen, C., Martin, F., Redemann, C., & Yau-Young, A. (1991) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(91)90246-5 · Cited by 1,391
Exploring polyethylenimine‐mediated DNA transfection and the proton sponge hypothesis
Akinc, A., Thomas, M., Klibanov, A. M., & Langer, R. (2005) · The Journal of Gene Medicine · doi:10.1002/jgm.696 · Cited by 1,337
Mechanism of DNA Release from Cationic Liposome/DNA Complexes Used in Cell Transfection,
Xu, Y., & Szoka, F. C. (1996) · Biochemistry · doi:10.1021/bi9602019 · Cited by 1,134
Kirpotin, D. B., Drummond, D. C., Shao, Y., Shalaby, M. R., Hong, K., Nielsen, U. B., Marks, J. D., Benz, C. C., & Park, J. W. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4199 · Cited by 1,125
Imaging of angiogenesis: from microscope to clinic
McDonald, D. M., & Choyke, P. L. (2003) · Nature Medicine · doi:10.1038/nm0603-713 · Cited by 1,016
Dhar, S., Gu, F. X., Langer, R., Farokhzad, O. C., & Lippard, S. J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0809154105 · Cited by 994
Aminopeptidase N is a receptor for tumor-homing peptides and a target for inhibiting angiogenesis.
Pasqualini, R., Koivunen, E., Kain, R., Lahdenranta, J., Sakamoto, M., Stryhn, A., Ashmun, R., Shapiro, L., Arap, W., & Ruoslahti, E. I. (2000) · PubMed · Cited by 966
Maeda, H., Sawa, T., & Konno, T. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00309-1 · Cited by 925
Yuan, F., Leunig, M., Huang, S. K., Berk, D. A., Papahadjopoulos, D., & Jain, R. K. (1994) · PubMed · Cited by 908
Schiffelers, R. M. (2004) · Nucleic Acids Research · doi:10.1093/nar/gnh140 · Cited by 901
Ross, J. F., Chaudhuri, P. K., & Ratnam, M. (1994) · Cancer · doi:10.1002/1097-0142(19940501)73:9<2432::aid-cncr2820730929>3.0.co;2-s · Cited by 891
A novel cationic liposome reagent for efficient transfection of mammalian cells
Gao, X., & Huang, L. (1991) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(91)91366-k · Cited by 847
RNA interference in the clinic: challenges and future directions
Pecot, C. V., Calin, G. A., Coleman, R. L., Lopez-Berestein, G., & Sood, A. K. (2011) · Nature Reviews Cancer · doi:10.1038/nrc2966 · Cited by 820
Evidence for the role of proteoglycans in cation-mediated gene transfer.
Mislick, K. A., & Baldeschwieler, J. D. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.22.12349 · Cited by 772
Anti-HER2 immunoliposomes: enhanced efficacy attributable to targeted delivery.
Park, J. W., Hong, K., Kirpotin, D. B., Colbern, G. T., Shalaby, R., Baselga, J. M., Shao, Y. Y., Nielsen, U. B., Marks, J. D., Moore, D. H., et al. (2002) · Clinical Cancer Research · Cited by 766
Mishra, S., Webster, P., & Davis, M. E. (2004) · European Journal of Cell Biology · doi:10.1078/0171-9335-00363 · Cited by 730
Efficient gene transfer into mammalian primary endocrine cells with lipopolyamine-coated DNA.
Behr, J. P., Demeneix, B., Loeffler, J. P., & Perez-Mutul, J. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.18.6982 · Cited by 719
Liposomes for the sustained drug release in vivo
Blume, G., & Cevc, G. (1990) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(90)90440-y · Cited by 698
Hatakeyama, H., Akita, H., & Harashima, H. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.09.001 · Cited by 645
Self-citationOn the mechanism whereby cationic lipids promote intracellular delivery of polynucleic acids
Hafez, I., Maurer, N., & Cullis, P. (2001) · Gene Therapy · doi:10.1038/sj.gt.3301506 · Cited by 601
Li, W. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.10.041 · Cited by 588 · cited 1×
“111) A 30-amino acid GALA contains a glutamic acid-alanine-leucine-alanine sequence that is repeated four times.”
Folate-mediated tumor cell targeting of liposome-entrapped doxorubicin in vitro
Lee, R. J., & Low, P. S. (1995) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(94)00235-h · Cited by 574
Anand, S., Majeti, B. K., Acevedo, L. M., Murphy, E. A., Mukthavaram, R., Scheppke, L., Huang, M., Shields, D. J., Lindquist, J. N., Lapinski, P. E., et al. (2010) · Nature Medicine · doi:10.1038/nm.2186 · Cited by 517
Lipid-based systemic delivery of siRNA
Tseng, Y.-C., Mozumdar, S., & Huang, L. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.03.003 · Cited by 463
Nanoparticle-mediated drug delivery to tumor vasculature suppresses metastasis
Murphy, E. A., Majeti, B. K., Barnes, L. A., Makale, M., Weis, S. M., Lutu-Fuga, K., Wrasidlo, W., & Cheresh, D. A. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803728105 · Cited by 455
Semple, S. C., Klimuk, S. K., Harasym, T. O., Dos Santos, N., Ansell, S. M., Wong, K. F., Maurer, N., Stark, H., Cullis, P. R., Hope, M. J., et al. (2001) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(00)00343-6 · Cited by 454
Leventis, R., & Silvius, J. R. (1990) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(90)90017-i · Cited by 430
Hatakeyama, H., Akita, H., Kogure, K., Oishi, M., Nagasaki, Y., Kihira, Y., Ueno, M., Kobayashi, H., Kikuchi, H., & Harashima, H. (2007) · Gene Therapy · doi:10.1038/sj.gt.3302843 · Cited by 398
Self-citationMamot, C., Drummond, D. C., Noble, C. O., Kallab, V., Guo, Z., Hong, K., Kirpotin, D. B., & Park, J. W. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1093 · Cited by 382
Reversible Cell‐Specific Drug Delivery with Aptamer‐Functionalized Liposomes
Cao, Z., Tong, R., Mishra, A., Xu, W., Wong, G. C. L., Cheng, J., & Lu, Y. (2009) · Angewandte Chemie International Edition · doi:10.1002/anie.200901452 · Cited by 372
Prospects of RNA interference therapy for cancer
Pai, S. I., Lin, Y.-Y., Macaes, B., Meneshian, A., Hung, C.-F., & Wu, T.-C. (2006) · Gene Therapy · doi:10.1038/sj.gt.3302694 · Cited by 352
Confirming the RNAi-mediated mechanism of action of siRNA-based cancer therapeutics in mice
Judge, A. D., Robbins, M., Tavakoli, I., Levi, J., Hu, L., Fronda, A., Ambegia, E., McClintock, K., & MacLachlan, I. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37515 · Cited by 336
Walker, G. F., Fella, C., Pelisek, J., Fahrmeir, J., Boeckle, S., Ogris, M., & Wagner, E. (2005) · Molecular Therapy · doi:10.1016/j.ymthe.2004.11.006 · Cited by 321
Sato, Y., Hatakeyama, H., Sakurai, Y., Hyodo, M., Akita, H., & Harashima, H. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.09.009 · Cited by 309
Self-citationIshida, O., Maruyama, K., Sasaki, K., & Iwatsuru, M. (1999) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(99)00256-2 · Cited by 308
Uster, P. S., Allen, T. M., Daniel, B. E., Mendez, C. J., Newman, M. S., & Zhu, G. Z. (1996) · FEBS Letters · doi:10.1016/0014-5793(96)00452-8 · Cited by 298
pH-sensitive liposomes: acid-induced liposome fusion.
Connor, J., Yatvin, M. B., & Huang, L. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.6.1715 · Cited by 287
Ogris, M. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(03)00230-x · Cited by 286
Li, S.-D., & Huang, L. (2006) · Molecular Pharmaceutics · doi:10.1021/mp060039w · Cited by 282
Gene therapy progress and prospects: synthetic polymer-based systems
Schaffert, D., & Wagner, E. (2008) · Gene Therapy · doi:10.1038/gt.2008.105 · Cited by 277
Meyer, M., Philipp, A., Oskuee, R., Schmidt, C., & Wagner, E. (2008) · Journal of the American Chemical Society · doi:10.1021/ja710344v · Cited by 263
Ishida, O., Maruyama, K., Tanahashi, H., Iwatsuru, M., Sasaki, K., Eriguchi, M., & Yanagie, H. (2001) · Pharmaceutical Research · doi:10.1023/a:1010960900254 · Cited by 257
Hatakeyama, H., Ito, E., Akita, H., Oishi, M., Nagasaki, Y., Futaki, S., & Harashima, H. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.06.008 · Cited by 254
Self-citationMatsumura, Y., Gotoh, M., Muro, K., Yamada, Y., Shirao, K., Shimada, Y., Okuwa, M., Matsumoto, S., Miyata, Y., Ohkura, H., et al. (2004) · Annals of Oncology · doi:10.1093/annonc/mdh092 · Cited by 253
Effective anti-tumor activity of oxaliplatin encapsulated in transferrin–PEG-liposome
Suzuki, R., Takizawa, T., Kuwata, Y., Mutoh, M., Ishiguro, N., Utoguchi, N., Shinohara, A., Eriguchi, M., Yanagie, H., & Maruyama, K. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.06.010 · Cited by 250
Proteoglycans Mediate Cationic Liposome-DNA Complex-based Gene Delivery in Vitro and in Vivo
Mounkes, L. C., Zhong, W., Cipres-Palacin, G., Heath, T. D., & Debs, R. J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.40.26164 · Cited by 245
pH‐sensitive liposomes mediate cytoplasmic delivery of encapsulated macromolecules
Straubinger, R. M., Düzgünes, N., & Papahadjopoulos, D. (1985) · FEBS Letters · doi:10.1016/0014-5793(85)80210-6 · Cited by 240
Manjappa, A. S., Chaudhari, K. R., Venkataraju, M. P., Dantuluri, P., Nanda, B., Sidda, C., Sawant, K. K., & Ramachandra Murthy, R. S. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.11.002 · Cited by 236
Pastorino, F., Brignole, C., Di Paolo, D., Nico, B., Pezzolo, A., Marimpietri, D., Pagnan, G., Piccardi, F., Cilli, M., Longhi, R., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-2117 · Cited by 232
Murthy, N., Campbell, J., Fausto, N., Hoffman, A. S., & Stayton, P. S. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(03)00099-3 · Cited by 221
Kogure, K., Moriguchi, R., Sasaki, K., Ueno, M., Futaki, S., & Harashima, H. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.04.024 · Cited by 218
Self-citationIshida, T., Kirchmeier, M. J., Moase, E. H., Zalipsky, S., & Allen, T. M. (2001) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(01)00409-6 · Cited by 216
Hatakeyama, H., Akita, H., Ito, E., Hayashi, Y., Oishi, M., Nagasaki, Y., Danev, R., Nagayama, K., Kaji, N., Kikuchi, H., et al. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.02.045 · Cited by 216
Self-citationPeer, D., & Margalit, R. (2004) · Neoplasia · doi:10.1593/neo.03460 · Cited by 214
Possibility of active targeting to tumor tissues with liposomes
Maruyama, K., Ishida, O., Takizawa, T., & Moribe, K. (1999) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(99)00042-3 · Cited by 211
Shin, J. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(03)00232-3 · Cited by 208
Kibria, G., Hatakeyama, H., Ohga, N., Hida, K., & Harashima, H. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.03.012 · Cited by 200
Self-citationNon-Viral Nucleic Acid Delivery: Key Challenges and Future Directions
Elsabahy, M., Nazarali, A., & Foldvari, M. (2011) · Current Drug Delivery · doi:10.2174/156720111795256174 · Cited by 199
Efficient Oncogene Silencing and Metastasis Inhibition via Systemic Delivery of siRNA
Li, S.-D., Chono, S., & Huang, L. (2008) · Molecular Therapy · doi:10.1038/mt.2008.51 · Cited by 198
Zalipsky, S., Qazen, M., Walker, J. A., Mullah, N., Quinn, Y. P., & Huang, S. K. (1999) · Bioconjugate Chemistry · doi:10.1021/bc990031n · Cited by 198
Terada, T., Iwai, M., Kawakami, S., Yamashita, F., & Hashida, M. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.12.023 · Cited by 197
Materializing the Potential of Small Interfering RNA via a Tumor-Targeting Nanodelivery System
Pirollo, K. F., Rait, A., Zhou, Q., Hwang, S. H., Dagata, J. A., Zon, G., Hogrefe, R. I., Palchik, G., & Chang, E. H. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4535 · Cited by 195
Stealth® liposomes: from theory to product
Cˇeh, B., Winterhalter, M., Frederik, P. M., Vallner, J. J., & Lasic, D. D. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(96)00456-5 · Cited by 191
Leamon, C. P., Cooper, S. R., & Hardee, G. E. (2003) · Bioconjugate Chemistry · doi:10.1021/bc020089t · Cited by 180
Targeting of stealth liposomes to erbB-2 (Her/2) receptor: in vitro and in vivo studies
Goren, D., Horowitz, A., Zalipsky, S., Woodle, M., Yarden, Y., & Gabizon, A. (1996) · British Journal of Cancer · doi:10.1038/bjc.1996.625 · Cited by 179
Folate-targeted, cationic liposome-mediated gene transfer into disseminated peritoneal tumors
Reddy, J. A., Abburi, C., Hofland, H., Howard, S. J., Vlahov, I., Wils, P., & Leamon, C. P. (2002) · Gene Therapy · doi:10.1038/sj.gt.3301833 · Cited by 173
ElBayoumi, T. A., & Torchilin, V. P. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2392 · Cited by 170
A liposome-based nanostructure for aptamer directed delivery
Kang, H., O’Donoghue, M. B., Liu, H., & Tan, W. (2010) · Chem. Commun. · doi:10.1039/b916911c · Cited by 169
Tumor targeting of doxorubicin by anti-MT1-MMP antibody-modified PEG liposomes
Hatakeyama, H., Akita, H., Ishida, E., Hashimoto, K., Kobayashi, H., Aoki, T., Yasuda, J., Obata, K., Kikuchi, H., Ishida, T., et al. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.04.037 · Cited by 165
Self-citationEliaz, R. E., Nir, S., Marty, C., & Szoka, F. C. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-0654 · Cited by 154
Masson, C., Garinot, M., Mignet, N., Wetzer, B., Mailhe, P., Scherman, D., & Bessodes, M. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.07.016 · Cited by 152
Hatakeyama, H., Akita, H., Maruyama, K., Suhara, T., & Harashima, H. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2004.05.025 · Cited by 147
Self-citationRemaut, K., Lucas, B., Braeckmans, K., Demeester, J., & Smedt, S. C. D. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.10.029 · Cited by 146
Modulation of Membrane Fusion by Asymmetric Transbilayer Distributions of Amino Lipids
Bailey, A. L., & Cullis, P. R. (1994) · Biochemistry · doi:10.1021/bi00208a007 · Cited by 146
Proteolytic Actuation of Nanoparticle Self‐Assembly
Harris, T. J., von Maltzahn, G., Derfus, A. M., Ruoslahti, E. I., & Bhatia, S. N. (2006) · Angewandte Chemie International Edition · doi:10.1002/anie.200600259 · Cited by 146
Design of Folate-Linked Liposomal Doxorubicin to its Antitumor Effect in Mice
Yamada, A., Taniguchi, Y., Kawano, K., Honda, T., Hattori, Y., & Maitani, Y. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0159 · Cited by 141
Li, W., Huang, Z. R., MacKay, J. A., Grube, S., & Szoka, F. C. (2004) · The Journal of Gene Medicine · doi:10.1002/jgm.634 · Cited by 140
Boeckle, S., Fahrmeir, J., Röedl, W., Ogris, M., & Wagner, E. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.02.002 · Cited by 132
Kim, S. H., Mok, H., Jeong, J. H., Kim, S. W., & Park, T. G. (2005) · Bioconjugate Chemistry · doi:10.1021/bc050289f · Cited by 129
Sakurai, Y., Hatakeyama, H., Sato, Y., Hyodo, M., Akita, H., & Harashima, H. (2013) · Molecular Therapy · doi:10.1038/mt.2013.57 · Cited by 124
Self-citationShir, A., Ogris, M., Wagner, E., & Levitzki, A. (2005) · PLoS Medicine · doi:10.1371/journal.pmed.0030006 · Cited by 124
Endosomal escape and the knockdown efficiency of liposomal-siRNA by the fusogenic peptide shGALA
Sakurai, Y., Hatakeyama, H., Sato, Y., Akita, H., Takayama, K., Kobayashi, S., Futaki, S., & Harashima, H. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.04.047 · Cited by 122
Self-citationPharmacokinetic and pharmacodynamic considerations in gene therapy
Kamiya, H., Akita, H., & Harashima, H. (2003) · Drug Discovery Today · doi:10.1016/s1359-6446(03)02889-7 · Cited by 121
Self-citationGabizón, A., Tzemach, D., Gorin, J., Mak, L., Amitay, Y., Shmeeda, H., & Zalipsky, S. (2009) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-009-1132-4 · Cited by 116
Oishi, M., Nagatsugi, F., Sasaki, S., Nagasaki, Y., & Kataoka, K. (2005) · ChemBioChem · doi:10.1002/cbic.200400334 · Cited by 111
Takara, K., Hatakeyama, H., Kibria, G., Ohga, N., Hida, K., & Harashima, H. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.06.019 · Cited by 105
Self-citationScherphof, G. L., DIJKSTRA, J., Spanjer, H. H., DERKSEN, J. T. P., & Roerdink, F. H. (1985) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1985.tb18414.x · Cited by 101
Smith, B. J., Lyakhov, I. G., Loomis, K. H., Needle, D., Baxa, U., Yavlovich, A., Capala, J., Blumenthal, R. P., & Puri, A. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.04.005 · Cited by 99
Shmeeda, H., Tzemach, D., Mak, L., & Gabizón, A. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.02.002 · Cited by 98
Schaffert, D. H., Kiss, M., Rödl, W., Shir, A., Levitzki, A., Ogris, M., & Wagner, E. (2011) · Pharmaceutical Research · doi:10.1007/s11095-010-0225-4 · Cited by 97
Zhang, J. X. (2003) · Pharmacological Research · doi:10.1016/j.phrs.2003.09.003 · Cited by 95
Lee, J. B., Zhang, K., Tam, Y. Y. C., Tam, Y. K., Belliveau, N. M., Sung, V. Y. C., Lin, P. J. C., LeBlanc, E., Ciufolini, M. A., Rennie, P. S., et al. (2011) · International Journal of Cancer · doi:10.1002/ijc.27361 · Cited by 92
Thioaptamer Conjugated Liposomes for Tumor Vasculature Targeting
Mann, A. P., Bhavane, R. C., Somasunderam, A., Montalvo-Ortiz, B. L., Ghaghada, K. B., Volk, D. E., Nieves-Alicea, R., Suh, K. S., Mauro Ferrari, B., Annapragada, A., et al. (2010) · Oncotarget · doi:10.18632/oncotarget.261 · Cited by 91
A Novel Cationic Amphiphile for Transfection of Mammalian Cells
Ruysschaert, J., Elouahabi, A., Willeaume, V., Huez, G. A., Fuks, R., Vandenbranden, M., & DiStefano, P. S. (1994) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1994.2372 · Cited by 91
A Multifunctional Envelope-type Nanodevice for Use in Nanomedicine: Concept and Applications
Nakamura, T., Akita, H., Yamada, Y., Hatakeyama, H., & Harashima, H. (2012) · Accounts of Chemical Research · doi:10.1021/ar200254s · Cited by 88
Self-citationRGD-based active targeting of novel polycation liposomes bearing siRNA for cancer treatment
Yonenaga, N., Kenjo, E., Asai, T., Tsuruta, A., Shimizu, K., Dewa, T., Nango, M., & Oku, N. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.10.004 · Cited by 86
Akita, H., Ishiba, R., Hatakeyama, H., Tanaka, H., Sato, Y., Tange, K., Arai, M., Kubo, K., & Harashima, H. (2013) · Advanced Healthcare Materials · doi:10.1002/adhm.201200431 · Cited by 84
Self-citationLipid Encapsulation Enables the Effective Systemic Delivery of Polyplex Plasmid DNA
Heyes, J. A., Palmer, L., Chan, K., Giesbrecht, C., Jeffs, L. B., & MacLachlan, I. (2007) · Molecular Therapy · doi:10.1038/sj.mt.6300101 · Cited by 78
Kogure, K., Akita, H., & Harashima, H. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.06.018 · Cited by 78
Self-citationEfficient gene delivery via non-covalent complexes of folic acid and polyethylenimine
Guo, W., & Lee, R. J. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00456-4 · Cited by 68
Paolo, D. D., Ambrogio, C., Pastorino, F., Brignole, C., Martinengo, C., Carosio, R., Loi, M., Pagnan, G., Emionite, L., Cilli, M., et al. (2011) · Molecular Therapy · doi:10.1038/mt.2011.142 · Cited by 64
Takara, K., Hatakeyama, H., Ohga, N., Hida, K., & Harashima, H. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.05.002 · Cited by 64
Self-citationDevelopment of anti-HB-EGF immunoliposomes for the treatment of breast cancer
Nishikawa, K., Asai, T., Shigematsu, H., Shimizu, K., Kato, H., Asano, Y., Takashima, S., Mekada, E., Oku, N., & Minamino, T. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.10.010 · Cited by 59
A multifunctional PEI-based cationic polyplex for enhanced systemic p53-mediated gene therapy
Moffatt, S., Wiehle, S., & Cristiano, R. J. (2006) · Gene Therapy · doi:10.1038/sj.gt.3302773 · Cited by 57
Lu, Y., Wu, J. H., Wu, J., Gonit, M., Yang, X., Lee, A., Xiang, G., Li, H., Liu, S., Marcucci, G., et al. (2007) · Molecular Pharmaceutics · doi:10.1021/mp070058l · Cited by 56
Beuttler, J., Rothdiener, M., Müller, D., Frejd, F. Y., & Kontermann, R. E. (2009) · Bioconjugate Chemistry · doi:10.1021/bc900061v · Cited by 53
Sakurai, Y., Hatakeyama, H., Akita, H., Oishi, M., Nagasaki, Y., Futaki, S., & Harashima, H. (2009) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.32.928 · Cited by 48
Self-citationEffective delivery of an angiogenesis inhibitor by neovessel-targeted liposomes
Katanasaka, Y., Ida, T., Asai, T., Maeda, N., & Oku, N. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.04.046 · Cited by 36
Kullberg, E. B., Nestor, M., & Gedda, L. (2003) · Pharmaceutical Research · doi:10.1023/a:1022223204460 · Cited by 28
Hatakeyama, H., Ito, E., Yamamoto, M., Akita, H., Hayashi, Y., Kajimoto, K., Kaji, N., Baba, Y., & Harashima, H. (2011) · Molecular Therapy · doi:10.1038/mt.2011.24 · Cited by 21
Self-citation
Cited by
PEGylation as a strategy for improving nanoparticle-based drug and gene delivery
Suk, J. S., Xu, Q., Kim, N., Hanes, J., & Ensign, L. M. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.09.012 · Cited by 4,523
Block copolymer micelles in nanomedicine applications
Cabral, H., Miyata, K., Osada, K., & Kataoka, K. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00199 · Cited by 1,309
Polyethylene glycol (PEG): A versatile polymer for pharmaceutical applications
D’souza, A. A., & Shegokar, R. (2016) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2016.1182485 · Cited by 1,282
“between them is requisite to maintain efficacy.[103]”
Design of liposomes as drug delivery system for therapeutic applications
Guimarães, D., Cavaco-Paulo, A., & Nogueira, E. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.120571 · Cited by 1,196
The role of lipid components in lipid nanoparticles for vaccines and gene therapy
Hald Albertsen, C., Kulkarni, J. A., Witzigmann, D., Lind, M., Petersson, K., & Simonsen, J. B. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114416 · Cited by 1,185
Metadata
- Authors
- Hatakeyama, H., Akita, H., & Harashima, H.
- Venue
- Biological and Pharmaceutical Bulletin
- Publisher
- Pharmaceutical Society of Japan
- Published
- 2013
- Volume
- 36
- Issue
- 6
- Pages
- 892-899
- ISSN
- 0918-6158 (ISSN-L)
- 1347-5215
- OpenAlex
- W2014928486
- Cited by
- 495
- References
- 122
- FWCI
- 10.22
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.